Registration - In-house Organization

Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG) / JAMES KEON, PRESIDENT

Registration Information

In-house Organization name: Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
Previous in-house organization names
Responsible Officer Name: JAMES KEON, PRESIDENT
Initial registration start date: 1998-07-22
Registration status: Active
Registration Number: 776966-548

Associated Communications

Total Number of Communication Reports: 394

Monthly communication reports in the last 6 months: 7

Version 55 of 55 (2025-02-05 to present)

Registration versions:

Version 55 of 55 (2025-02-05 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Industry	Discussions with ISED towards a national strategy for the biomanufacturing and the life sciences sector.	Policies or Program
Health	Health Canada regarding the development of a national pharmacare strategy.	Policies or Program
Health, Industry	Health Canada with respect to its Regulatory Systems Review for Therapeutic Products.	Regulation, Policies or Program
Health, Industry	Health Canada with respect to the process for the approval and renewal of foreign sites for Drug Establishment License (DEL) holders. Related guidance documents include the Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080), the Guidance on Drug Establishment Licences and Drug Establishment Licensing Fees (GUI-0002) and the Guidance on Good Manufacturing Practices for Active Pharmaceutical Ingredients (GUI-0104).	Policies or Program
Health, Industry	Health Canada with respect to user fees for therapeutic product regulatory programs.	Policies or Program, Legislative Proposal, Bill or Resolution, Regulation
Industry	Innovation, Science and Economic Development Canada (ISED) Innovation Agenda regarding the need for a balanced intellectual property regime and the important role competition plays in encouraging innovation.	Policies or Program
Health, Industry, International Trade	Participate in Government of Canada consultations with respect to the Regulatory Cooperation Council.	Policies or Program, Regulation
Health, Industry	Participation in Competition Bureau consultations with respect to pharmaceuticals.	Policies or Program
Health	Proposals related to Health Canada's Identical Medicinal Ingredient Policy.	Policies or Program
Health	Proposals to enhance transparency of the Health Canada Reconsiderations Policy for drug submissions.	Policies or Program
Health, Industry	Provide input into policy discussions with respect to the implementation of a national pharmacare program.	Legislative Proposal, Bill or Resolution
Health, Industry, International Trade	Provide input into the Canada-United States-Mexico Agreement (CUSMA).	Legislative Proposal, Bill or Resolution
Health, Industry, Internal Trade, International Relations, International Trade, Taxation and Finance	Provide input into the Canada-US trade relationship as it pertains to medicines, including the impact of tariffs on medicines and medicine manufacturing inputs for the Canadian healthcare system, patients and industry.	Policies or Program
Industry, International Trade	Provide input into the Government of Canada's negotiations regarding trade negotiations with respect to pharmaceuticals, counterfeit medicines, and intellectual property.	Legislative Proposal, Bill or Resolution
Health, Industry	Provide input into the modernization of the Food and Drugs Act and related Regulations, Guidelines and Policies as they pertain to pharmaceuticals.	Regulation, Policies or Program, Legislative Proposal, Bill or Resolution
Industry	Provide input into the Patented Medicine Prices Review Board (PMPRB) consultations regarding its Policies, Guidelines and Procedures.	Policies or Program
Health, Industry	Providing input with respect to the approval pathway for biosimilar medicines by Health Canada.	Policies or Program
Health, Industry	Seeking harmonization of regulatory regimes and administrative processes nationally and internationally.	Policies or Program
Health, International Trade	To encourage the Government of Canada to continue to participate in truly international discussions with respect to effective measures to combat substandard and falsified medicines in Canada and around the world.	Policies or Program

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Canada Border Services Agency (CBSA)
Canadian Heritage (PCH)
Canadian International Trade Tribunal (CITT)
Competition Bureau Canada (COBU)
CUSMA Secretariat
Employment and Social Development Canada (ESDC)
Environment and Climate Change Canada (ECCC)
Export Development Canada (EDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
National Defence (DND)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Safety Canada (PS)
Public Services and Procurement Canada (PSPC)
Senate of Canada
Transport Canada (TC)
Treasury Board Of Canada Secretariat (TBS)
Veterans Affairs Canada (VAC)

In-house Organization Details

Description of the organization's activities

The Canadian Generic Pharmaceutical Association's mission is to promote an environment which supports and enhances the provision of affordable generic and biosimilar medicines to Canadians and patients around the world through research, development and manufacturing of pharmaceuticals and fine chemicals in Canada. Through its Biosimilars Canada division, it provides leadership in educating Canadian stakeholders about biosimilar medicines, and advocating for policies that support their approval, reimbursement and market acceptance.

Responsible officer name and position during the period of this registration

JAMES KEON, PRESIDENT

Organization's membership or classes of membership

The Canadian Generic Pharmaceutical Association represents manufacturers and distributors of finished generic pharmaceutical products, manufacturers and distributors of active pharmaceutical chemicals, and suppliers of other goods and services to the generic pharmaceutical industry. Through its Biosimilars Canada division, it provides leadership in educating Canadian stakeholders about biosimilar medicines, and advocating for policies that support their approval, reimbursement and market acceptance.

Government funding

No government funding was received during the last completed financial year.

In-house Organization Contact Information

Address:
501 - 4100 Yonge Street
Toronto, ON M2P 2B5
Canada

Telephone number: 416-223-2333
Fax number: 416-223-2425

Lobbyists Details

Employees who lobby for the organization

Jeff Connell, Vice President, Corporate Affairs | No public offices held
Jody Cox, Vice President, Federal and International Affairs | Public offices held
James Keon, President | Public offices held
Kristin Willemsen, Vice President, Scientific and Regulatory Affairs | No public offices held

Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG)

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG)	2008-08-01	current
CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA)	2008-08-01	2008-08-01

The following names have been used before July 2, 2008

CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA)
Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG)
CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA)

Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Special Assistant, Communications House of Commons, Progressive Conservative's Leader Office	March 2000 to January 2001	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Acting Director General Industry Canada, Consumer Affairs	1994 to 1994	Not a designated office
Regional Director Consumer and Corporate Affairs, B.C. and Yukon	1991 to 1993	Not a designated office
Director Consumer and Corporate Affairs, Intellectual Property	1988 to 1991	Not a designated office
Senior Analyst Consumer and Corporate Affairs, Consumer Affairs	1987 to 1988	Not a designated office
Policy Analyst Consumer and Corporate Affairs, Intellectual Property	1978 to 1986	Not a designated office
Research Analyst Statistics Canada, Industry Statistics	1977 to 1978	Not a designated office

Date Modified:: 2025-03-12

Search and menus

Language selection

Registration - In-house Organization

Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG) / JAMES KEON, PRESIDENT

Registration Information

Associated Communications

Version 55 of 55 (2025-02-05 to present)

Version 55 of 55 (2025-02-05 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Description of the organization's activities

Responsible officer name and position during the period of this registration

Organization's membership or classes of membership

Government funding

In-house Organization Contact Information

Employees who lobby for the organization